FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry and represents dermatological cream, intended for local treatment of bacterial skin infections and for healing wounds associated with them, which contains framycetin sulfate and biopolymer, included into cream base, which contains at least one substance from each of the following groups: preservative, primary and secondary emulsifier, selected from the group which contains ketostearyl alcohol, ketomacrogol 1000, polysorbate-80 and Span-80; paraffin as wax-like product, cosolvent, selected from the group, including propylene glycol, hexylene glycol and polyethylene glycol-400; nitric acid or lactic acid and water, with said biopolymer preferably being chitosan.
EFFECT: invention provides higher therapeutic effect.
8 cl, 10 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| CREAM FOR MEDICAL APPLICATION CONTAINING FUSIDIC ACID PREPARED WITH USING SODIUM FUSIDATE AND CONTAINING BIOPOLYMER, AND METHOD FOR PREPARING IT | 2010 |
|
RU2537023C2 |
| ANTIBIOTIC FOR TOPICAL APPLICATION CONTAINING A PHARMACEUTICAL COMPOSITION FOR TREATING BACTERIAL INFECTIONS AND WOUND HEALING | 2020 |
|
RU2812927C1 |
| NEW DERMATOLOGICAL CREAM PREPARED WITH USE OF SODIUM FUSIDATE | 2009 |
|
RU2536252C2 |
| PRODUCING METHOD OF CREAM CONTAINING FUSIDIC ACID | 2010 |
|
RU2536426C2 |
| COMBINED PHARMACEUTICAL COMPOSITION FOR EXTERNAL APPLICATION | 2018 |
|
RU2736940C2 |
| REMEDY WITH ANTIFUNGAL ACTIVITY BASED ON METAL SOLS | 2021 |
|
RU2763885C1 |
| LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
| NOVEL SYNERGISTIC PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION | 2010 |
|
RU2571506C2 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL USE, BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2348400C1 |
| TOPICAL ANTIMICROBIAL DERMATOLOGICAL COMPOSITION | 2014 |
|
RU2668827C2 |
